logo
episode-header-image
Sep 18
22m 31s

Wary pharma: AstraZeneca sours on UK

The Economist
About this episode

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean are restoring the barrier reef through “coral IVF”. 


Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+


For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.


Hosted on Acast. See acast.com/privacy for more information.

Up next
Yesterday
Liberté, égalité, désordre: chaos in France
France’s newly-appointed prime minister has resigned only weeks into the job. Now President Emmanual Macron has given him 48 hours to come up with a plan for next year’s budget. Can Macron survive the turmoil? As driverless taxis take over San Francisco, what will happen to the h ... Show More
21m 3s
Oct 7
Man of steel, and aluminium: Carney talks trade with Trump
The swiftest way for Prime Minister Mark Carney to ease pressure on Canada’s economy is to convince President Donald Trump today to pare back tariffs. But he has far broader plans afoot, too. A heady online mix of e-commerce and entertainment is creating a new generation of shopp ... Show More
21m 58s
Oct 6
One peace at a time: hopeful Gaza talks
As negotiators gather in Egypt, appetite for a short-term peace seems high on all sides. But there is much ambiguity surrounding a lasting accord. In New York, renters fear being evicted far less than they once did—but pity flat-hunters. And remembering Kim Seong Min, a North Kor ... Show More
22m 54s
Recommended Episodes
Sep 18
Wary pharma: AstraZeneca sours on UK
Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ... Show More
22m 31s
Sep 2
Call the shots: vaccine cuts imperil global health
America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ... Show More
21m 26s
Aug 20
Trouble in paradise: US plans for Pacific war
With China as its new rival, America is reviving old wartime facilities across the Pacific. Our correspondent visits an abandoned airfield that has been given new life. The outlook for climate technology is surprisingly bright. And why the universe of Hello Kitty keeps expanding. ... Show More
22m 34s
Apr 2025
Doomed traders: Trump’s tariff fallout
Since Donald Trump announced punishing tariffs on “Liberation Day” last week, stock markets have fallen and governments and businesses scrambled to respond. Our correspondent discusses the impact on the global economy. Do personalised diets really improve gut health (9:16)? And g ... Show More
21m 20s
Apr 2024
Money Talks: Why weight-loss drugs will reshape the world
More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs that ... Show More
36m 59s
Jan 2025
Putty people: can Trump get his picks?
As some of Donald Trump’s most controversial choices for top jobs are questioned this week, our correspondent analyses how supine Republicans may be in his second term. Has the luxury business passed its peak (09:57)? And why scientists are finding new ways to deal with an invasi ... Show More
23m 20s
Sep 16
Honey, we shrunk the kids: population fall
Falling fertility makes a global decline in population inevitable. That will change the shape and make up of societies. But it may not make us poorer. Are large language models really woke? And reading is on the wane – and why that matters. Listen to what matters most, from globa ... Show More
23m 46s
Aug 21
Stake and chips: will America take 10% of Intel?
Intel was once synonymous with chip-making, but in recent years it has fallen behind. Now the Trump administration may become its biggest shareholder. A political assassination in Colombia raises fears about a return to violence. And what an annual snail race tells us about rural ... Show More
21m 2s
Feb 2025
Love match: Modi-Trump’s tariffs tussle
The American president and Indian prime minister have long been friends. But when the two met at the White House yesterday, they had many thorny issues to discuss, including trade and immigration. Why the skies are getting smaller–and more crowded (10:40). And “Saturday Night Liv ... Show More
24m 30s
Mar 2025
Conversation peace: can Europe bargain with Russia?
European leaders met in London this weekend after Donald Trump and Volodymyr Zelensky’s public row shattered hopes for a US-led truce in Ukraine. What did the summit achieve? Our correspondent visits Mexico’s border to find out if strengthened force will stem the flow of fentanyl ... Show More
24m 45s